
FDA's Plans To Phase Out Animal-Testing In Drug Development Triggers Sell-Off In This Stock
The outsourced clinical research services provider's shares tumbled after the U.S. drug regulator announced a new approach to drug testing Key Takeaways: Joinn Labs' shares fell on heavy trading as investors worried about a shift in U.S. policy to …